JZJing Zhu

Jing Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jing Zhu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Ke Hu

    Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China

    2 shared publications
  • Rujuan Wang

    Department of Pulmonary and Critical Care Medicine , The Central Hospital of Wuhan, Tongji Medical College Wuhan, Hubei 430014 , China

    2 shared publications
  • Wenhao Cao

    Department of Pulmonary and Critical Care Medicine , The Central Hospital of Wuhan, Tongji Medical College Wuhan, Hubei 430014 , China

    2 shared publications
  • Xiuwen Yang

    Department of Pulmonary and Critical Care Medicine , The Central Hospital of Wuhan, Tongji Medical College Wuhan, Hubei 430014 , China

    2 shared publications
  • Mengqing Xiong

    Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China

    1 shared publication
  • Ming Li Yuan

    Department of Pulmonary and Critical Care Medicine, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    1 shared publication

Latest Publications

  • Effect of lung volume on the apnea hypopnea index in patients with overlap syndrome: a single center study

    by Jing Zhu, Xiaofeng Wu, Yi Hu, Xiuyi Yang, Xu Liu, Mengqing Xiong, Ke Hu

    Purpose This study aimed to evaluate the relationship between lung volume and apnea-hypopnea index (AHI) in patients with overlap syndrome (OVS). Methods Chronic obstructive pulmonary disease (COPD) patients diagnosed by spirometry were recruited from Renmin Hospital of Wuhan University. They were asked to take an overnight polysomnography (PSG). Multiple regression analyses were used to assess the relationships between lung volume measures and AHI in OVS patients. Results Finally, 354 OVS patients and 229 patients with only COPD met the study’s entry criteria. After adjusting for age, sex, BMI, neck size, economic status, smoking, alcohol use, and hypertension, residual volume (RV), total lung capacity (TLC), and the RV/TLC ratio each had a negative link with the AHI in OVS patients (RV: exp(β) = 0.903; 95% CI, 0.852 to 0.957; P < 0.05; TLC: exp(β) = 0.947; 95% CI, 0.899 to 0.998; P < 0.05; RV/TLC: exp(β) = 0.898; 95% CI, 0.846 to 0.954; P < 0.01). However, when RV was added as a covariate in the model, forced expiratory volume in one second (FEV1) had no association with the AHI in OVS patients (P > 0.05). Also, when dividing OVS patients by lung function severity, RV had a negative correlation with the AHI in those with Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3–4 grade (exp(β) = 0.905; 95% CI, 0.835 to 0.980; P < 0.05), but in GOLD 1–2 grade patients, there was no link between RV and AHI (P > 0.05). Conclusion The higher residual volume was independently associated with lower AHI in patients with overlap syndrome, particularly among patients with GOLD 3–4 airflow limitation.

  • Open Access

    Causal Association Between Lung Cancer and Rash: A Bidirectional Mendelian Randomization Study

    by Yang Xiao, Tian-Tian Li, Ming Li Yuan, Wen Yin, Jing Zhu

    Background: Skin involvement is one of the many clinical manifestations of lung cancer patients. However, there are fewer in-depth studies exploring the causal relationship between skin rashes and lung cancer subtypes, and the causal relationship is unknown. This study aims to explore the potential causal relationship between rash development and lung cancer diagnosis. Methods: From the Genome-wide Association Studies (GWAS) database, we sourced comprehensive data on skin rash, lung cancer, and gene expression Quantitative Trait Loci (eQTL). Drawing from this, we conducted a comprehensive analysis that integrated Mendelian Randomization (MR), protein-protein network analysis, and enrichment analysis to explore the causal relationship and potential mechanisms between rash and lung cancer. Results: This study reveals an increased risk of rash in small and squamous cell lung cancer patients, with odds ratios of 1.08 and 1.26, respectively. However, no causal link between rash and lung cancer was found. Genetic analysis identified 3 genes positively associated with both conditions and 6 negatively associated, suggesting complex genetic interactions. Sensitivity analysis did not indicate heterogeneity or pleiotropy. Conclusions: Our study shows that squamous cell lung cancer patients are more likely to get skin rashes. But the rash is not directly linked to lung cancer. Future research should explore rashes as a therapeutic target and prognostic indicator.

  • The causality between C-reactive protein and asthma: a two-sample Mendelian randomization analysis

    by Yong Mou, Wenhao Cao, Rujuan Wang, Xiaofan Liu, Xiuwen Yang, Jing Zhu

    Purpose: This study sought to investigate the causal effects of circulating C-reactive protein (CRP) level on risk of asthma and its subtypes by two-sample Mendelian randomization (MR) analysis. Methods: We utilized single nucleotide polymorphisms (SNPs) associated with both CRP and outcomes of asthma, allergic asthma, and obesity-related asthma as genetic variables via a genome-wide summary association study (GWAS). MR analysis mainly based on the inverse variance weighted (IVW) method was performed to infer the causal relationship between exposure and outcomes. Cochran’s Q test and MR-Egger regression analysis were performed to determine respectively the heterogeneity and pleiotropy among instrumental variables (IVs), and leave-one-out analysis was conducted to determine the stability of the MR results. Results: In our study, 42 SNPs were identified as IVs for MR analyses. According to the primary inference results by IVW methods, circulating CRP was demonstrated to be significantly associated with risk of asthma [odds ratio (OR): 1.046; 95% confidence interval (95% CI): 1.004–1.090; P = .030] and obesity-related asthma (OR: 1.072; 95% CI: 1.009–1.138; P = 0.025), whereas no distinct causality with allergic asthma was found (OR: 1.051; 95% CI: 0.994–1.112; P = .081). Sensitivity analyses indicated that there was no horizontal pleiotropy among IVs, and the MR results were proved to be robust by leave-one-out sensitivity analysis, despite the presence of heterogeneity. Conclusion: The present study suggested that higher CRP might genetically predict an increased risk of developing asthma and obesity-related asthma, without causality with allergic asthma.


  • Open Access

    The causality between C-reactive protein and asthma: A Two-Sample Mendelian Randomization Analysis

    by Yong Mou, Wenhao Cao, Rujuan Wang, Xiaofan Liu, Xiuwen Yang, Jing Zhu

    Background: C-reactive protein (CRP) plays a critical role in asthma development and is usually elevated in asthmatic patients. However, the causal association between CRP and asthma remains unknown. Results: We utilized single nucleotide polymorphisms (SNPs) associated with both CRP and outcomes of asthma, allergic asthma and obesity related asthma as genetic variables via genome-wide summary association study (GWAS). In our study, 42 SNPs were identified as instrumental variables (Ivs) for mendelian randomization (MR) analyses. According to the primary inference results by inverse variance weighted (IVW)methods, the circulating CRP was demonstrated to be significantly associated with risk of asthma (OR=1.046, 95%CI 1.004-1.090, P=0.030) and obesity related asthma (OR=1.072, 95%CI 1.009-1.138, P=0.025), whereas no distinct causality with allergic asthma (OR=1.051, 95%CI 0.994-1.112, P=0.081). Sensitivity analyses indicated that there’s no horizontal pleiotropy among IVs, and the MR results were proved to be robust by leave-one-out sensitivity analysis, despite of the presence of heterogeneity. Conclusions:The present study suggested that genetically determined circulating CRP showed an increased risk of developing asthma and obesity related asthma, without causality with allergic asthma.

  • Effect of lung function on the apnea-hypopnea index in patients with overlap syndrome: a multicenter cross-sectional study

    by Jing Zhu, Zhiling Zhao, Qingrong Nie, Yingnan Wang, Zhen Fu, Xiheng Guo, Ke Hu

    Purpose Patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are referred to as having overlap syndrome (OVS). However, the relationship of lung function with the apnea-hypopnea index (AHI) in patients with OVS has not been evaluated. This multicenter study aimed to evaluate the relationship. Methods COPD patients diagnosed by spirometry were recruited from four Chinese tertiary hospitals. Those patients were requested to attend an overnight polysomnography (PSG). The relationships between parameters of lung function and sleep respiration in patients with OVS were assessed using multiple regression analyses. Results A total of 520 OVS patients and 246 patients with COPD only finally met inclusion criteria for study. After adjustment for age, sex, body mass index, neck circumference, economic status, smoking status, alcohol consumption, and hypertension, the forced expiratory volume in the first second (FEV1) had a positive correlation with the AHI in patients with OVS (β, 0.17; 95% CI, 0.06–0.28; P < 0.01). However, when the severity of lung function of patients with OVS was stratified, the correlation with the FEV1 of each grade and the AHI was absent (P > 0.05). Additionally, The FEV1 was positively correlated with the nadir oxygen saturation (SaO2) (β, 0.18; 95% CI, 0.08–0.27; P < 0.01) and was negatively correlated with the percentage of time spent with an SaO2 below 90% (TS90%) (β,− 0.41; 95% CI,− 0.61–0.21; P < 0.01) in patients with OVS using multiple regression analyses. Conclusion Lung function was associated with the AHI in patients with OVS. The lower FEV1 may play some protective role in the severity of AHI in OVS patients. Trial registry ClinicalTrials.gov, No.: NCT 03182309, URL: www.clinicaltrials.gov.